FDA approval of PEPAXTO - Webcast for investors, analysts and the media

In conjunction with the FDA approval of PEPAXTO, Oncopeptides hosted a webcast March 1, 2021, at 07:30 (CET), including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas Bakker, and CFO Anders Martin-Löf.

The conference call was recorded and available on the link below.

Read the press release here